Executive Team

Under Schechter’s leadership, Labcorp, a leading global life sciences company with more than 80,000 employees, harnesses science, innovation and technology to improve health and improve lives. Through its unparalleled diagnostics and drug development capabilities, vast health data and insights, and extensive global laboratory network, the company advances healthcare across all major clinical and therapeutic areas, including oncology, Alzheimer’s, autoimmune and liver diseases, and more.

Labcorp is helping customers bring innovative, life-changing treatments and vaccines to market by leveraging its combined expertise in drug development and diagnostics. With these capabilities, Schechter with his colleagues at Labcorp, created a model for addressing emerging health crises with their response to the COVID-19 pandemic and the mpox virus.

Schechter joined Labcorp after a long and distinguished career at Merck, where he served as executive vice president and president of global human health and was a member of the executive committee. At Merck, among other accomplishments, Schechter focused on ensuring that Merck’s medicines and vaccines were available to people around the world; led a large global organization across the spectrum of commercial operations; transformed Merck’s commercial model; and led the integration of Merck and Schering-Plough.

He is the vice chair of the Board of Directors for the American Clinical Laboratory Association (ACLA), a board member for Water.org, and serves as an independent director on the board of DaVita, Inc. Schechter is chair of the Corporate Advisory Council for the National Alliance for Hispanic Health, a longtime leader and advocate on Hispanic issues and an Executive Advisor to its Healthy Americas Foundation.

Schechter holds a Bachelor of Arts in Biology from La Salle University and was awarded an honorary Doctor of Humane Letters degree from the university in 2021.

Adam Schechter's LinkedIn Profile

Prior to that, he served as the Chief Information Officer at IDEXX Laboratories, Inc., a global leader in diagnostics and IT solutions for animal health and food and water quality. Lance also worked as Chief Information Officer and President of Kellstrom Defense Aerospace Inc., a fully integrated supply chain firm, from 2000 to 2007. Prior to that, he was the Chief Information Officer of Interim HealthCare Inc. Lance is a strategic advisory board member for North Carolina State University’s Department of Computer Science. He holds a B.S. in both business administration and information technology from Thomas Edison State College.

Lance Berberian's LinkedIn Profile

Brian is a nationally recognized health policy expert, and in his current role as Chief Medical Officer, he oversees medical and scientific strategy. Before joining Labcorp in 2017, he was Chief Medical Officer at Blue Cross and Blue Shield of North Carolina. In addition to various roles in the healthcare division of the core health plan, Brian also served as Chief Clinical Officer of Mosaic Health Solutions, a wholly owned subsidiary of Blue Cross NC for strategic investments in diversified health solutions businesses. Prior to that role, he was a practicing physician and assistant professor at Duke University Medical Center and also provided consulting services for several companies in the Research Triangle Park, North Carolina region. Brian holds an M.D. from the West Virginia University School of Medicine, a J.D. from the West Virginia University College of Law, and an M.P.H. in health policy and administration from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board-certified in preventive medicine, with a specialty in occupational and environmental medicine. 

Dr. Brian Caveney's LinkedIn Profile

Prior to joining Labcorp, he served as Executive Vice President, Finance and Administration, and Chief Financial Officer at The Timken Company, a leading global manufacturer of highly engineered bearings and alloy steels and related products and services.  He also previously served as President and Chief Operating Officer of United Dominion Industries Ltd., a global diversified industrial company that is now a subsidiary of SPX Corporation, after working in several executive roles at the company, including Executive Vice President, Chief Financial Officer, and President of its test instrumentation segment. Glenn serves on the board of directors of US Ecology, Inc. (NASDAQ: ECOL) and of Perspecta Inc. (NYSE: PRSP). He previously served on the boards of directors of Family Dollar Stores Inc. and Alpha Natural Resources Inc. He received his B.A. from Tulane University and his M.B.A. from Georgia State University.

Glenn Eisenberg's LinkedIn Profile

Paul joined Labcorp in 2009 and has held several leadership positions, including Senior Vice President and Head of Covance’s clinical trial testing solutions, Senior Vice President of Covance Central Laboratories, Vice President and General Manager of Americas with Covance Central Laboratories, and Vice President Global Laboratory Operations and Medical Affairs with Covance Central Laboratory. Prior to joining Labcorp, he was Vice President and Global Medical Director for Quintiles Laboratories Ltd. (now Q² Solutions), where he was responsible for oversight of wholly-owned laboratories in the U.S., Singapore, South Africa, India and China. He also served as their Senior Director of Laboratory Services and North American Medical Director. Paul holds an M.D. from Cornell University, an M.B.A. from Binghamton University and three board certifications from the American Board of Pathology.

Dr. Paul Kirchgraber's LinkedIn Profile

Pike has more than 30 years of industry experience. Most recently, he co-founded, advised and served as a director for several healthcare and technology services companies with a focus on patients and clinical research sites. Pike served as CEO and board member of Quintiles Transnational Holdings, Inc. (Quintiles), a leading fully integrated biopharmaceutical services company offering clinical, commercial and consulting solutions worldwide. Under Pike’s leadership, the company launched Q2 Solutions, a clinical trial laboratory services organization, in a joint-venture transaction. Pike led Quintiles through a successful IPO, helping it grow into a Fortune 500 company with 36,000 employees worldwide.

Pike had a distinguished career at Accenture in executive roles, including Chief Risk Officer and Managing Director of the North America Health and Products business areas. Prior to that, he was the global Chief Operating Officer for Accenture’s Resources operating group, and he also served as Accenture’s Chief Strategy Officer and a member of the executive leadership team for Accenture’s IPO in July 2001. Earlier, he was at McKinsey & Company and currently serves on the board of Martin Marietta Materials, Inc. (MLM).

Pike earned his Bachelor of Science in accounting from the University of Delaware.

Thomas Pike's LinkedIn Profile

Since joining the company in 2007, Mark has held senior leadership positions in supply chain operations, including serving as Chief Supply Chain Officer from 2016 to 2019. Prior to joining Labcorp, he was the Senior Vice President of Sales, Operations and Business Development at DSC Logistics. Mark serves on the FedEx Healthcare Industry Advisory Board and is on the board of Labcorp’s venture fund. He earned a B.S. in interdisciplinary engineering and management from Clarkson University.

Mark Schroeder's LinkedIn Profile

Prior to her current role, she served as Senior Vice President and Chief Human Resources Officer. Before joining Labcorp, she served as the Chief Human Resources officer at Diversey, a global provider of sustainable hygiene technologies, services and solutions for cleaning, food safety and infection prevention. Prior to Diversey, Judi was Senior Vice President of Human Resources for the Global Human Health division of Merck and Co., from 2003 until 2018. She also worked at Hughes Network Systems and ARINC. A Certified Compensation Professional, Judi holds a B.A. degree from the University of Richmond and an M.A.S. in Human Resources Management from the Johns Hopkins University Carey Business School.

Judi Seltz's LinkedIn Profile

Prior to joining the company, she was Principal, Marketing & Insights Lead for the Americas for Ernst & Young from 2018 to 2020. Before that role, she served as Senior Vice President and Chief Marketing Officer for TE Connectivity Ltd. from 2011 to 2018, where she led marketing, digital, analytics and communications globally. Amy also worked for Sapient from 1996 to 2011, where she held executive leadership roles, including Managing Director for its New York and West Coast offices, and Chief Marketing Officer. Prior to Sapient, she held roles in sales management and product marketing at Dun & Bradstreet. She co-founded and is a board member for No More Kids with Cancer, which is dedicated to accelerating the discovery of safer, less toxic and more effective treatments for children with cancer, and she serves on the Corporate Council and Brain Tumor Research Board of Visitors for The Children’s Hospital of Philadelphia. She holds a B.B.A. from Kent State University and an M.B.A. in finance from New York University’s Stern School of Business.

Amy Summy's LinkedIn Profile

Prior to her current role, Sandy served as Senior Vice President, Global General Counsel, Chief Compliance Officer and Corporate Secretary. Prior to that, she served as Labcorp’s Senior Vice President, Deputy Chief Legal Officer from September 2015 until February 2019 and Senior Vice President, General Counsel and Assistant Secretary from January 2009 to September 2015. She has been with Labcorp since 2001 and has served in various other roles within the legal department. Prior to joining Labcorp, Sandy was a member of the Health Care Practice Group with Smith, Helms, Mulliss & Moore, and also previously worked for the North Carolina Medical Society as Director of the Society’s Managed Care Department. She is a member of the Association of Corporate Counsel and previously served as Chair of the Health Law Section Council of the North Carolina Bar Association and as President of the North Carolina Society of Healthcare Attorneys. Sandy obtained her B.S. in nursing from the University of North Carolina at Chapel Hill and her J.D. from the University of Virginia School of Law.

Sandy van der Vaart's LinkedIn Profile